Quoin Pharmaceuticals, Ltd.
QNRX
$5.91
-$0.16-2.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.35M | -3.95M | -3.70M | -3.81M | -2.31M |
| Total Depreciation and Amortization | 25.00K | 25.00K | 25.00K | 25.00K | 25.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 206.20K | 184.40K | 247.60K | 293.30K | 261.30K |
| Change in Net Operating Assets | -917.80K | 1.51M | -262.90K | 899.70K | -211.50K |
| Cash from Operations | -5.04M | -2.23M | -3.69M | -2.59M | -2.24M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.27M | 2.54M | 1.68M | 2.77M | -3.18M |
| Cash from Investing | -11.27M | 2.54M | 1.68M | 2.77M | -3.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -150.00K | -150.00K | -150.00K | -150.00K | -150.00K |
| Issuance of Common Stock | 18.44M | 0.00 | 0.00 | 173.00K | 6.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.29M | -150.00K | -150.00K | 23.00K | 5.92M |
| Foreign Exchange rate Adjustments | -600.00 | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.99M | 162.40K | -2.15M | 198.80K | 506.60K |